Bioactive Compounds
-
A3285 CB 300919Summary: Potential therapy for ovarian cancer -
A3289 CCG-63802Summary: RGS protein inhibitor -
A3299 CevimelineSummary: Muscarinic receptor agonist -
A3304 CGS 21680Summary: Adenosine A2 receptor agonists,potent and selective -
A3305 CHAPSSummary: Zwitterionic detergent for membrane proteins,nondenaturing -
A3307 CHIR-090Summary: Potent LpxC inhibitor -
A3309 CHR-6494Summary: Haspin inhibitor,potent ands selective -
A3313 CinacalcetSummary: Calcimimetic agent,orally active -
A3314 CinaciguatTarget: guanylyl cyclaseSummary: Soluble guanylate cyclase (sGC) activators -
A3325 Collagen proline hydroxylase inhibitorSummary: Collagen proline hydroxylase inhibitor

